| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Jan―17 |
COVID-19 as a turning point in the need for specialized units for the sense of smell |
A Izquierdo-Domínguez, C Calvo-Henríquez, JC Ceballos, M Rodriguez-Iglesias, J Mullol, I Alobid |
| 2 |
[GO] |
2022―Dec―20 |
A Prospective Validation of a Diagnostic Algorithm for Hypersensitivity Reactions to COVID-19 Vaccines |
N Rodríguez-Otero, E Granados-Alarcón, D Antolín-Amérigo, C Solórzano-Zepeda, M Blázquez-Fernández, M Grandal-Platero, B De la Hoz-Caballer |
| 3 |
[GO] |
2022―Oct―11 |
Monitoring Fractional Exhaled Nitric Oxide Levels in Adult Patients With Acute Symptomatic COVID-19 Infection: Non Sequitur? |
ZZ Elfessi, I Rubinstein |
| 4 |
[GO] |
2022―Oct―11 |
The Discrepant Role of Fractional Exhaled Nitric Oxide in SARS-CoV-2 Infection |
D Betancor, JM Olaguibel, J Sastre |
| 5 |
[GO] |
2022―Jul―26 |
SARS-CoV-2 Infection among Patients with Mastocytosis: An EPICOVIDEHA Report |
M Criscuolo, J Salmanton-García, N Fracchiolla, G Dragonetti, N Khanna, B Weinbergerová, M Schönlein, M Machado, J Labrador, M Kolditz, F Itri, M Gomes da Silva, V Bonuomo, M Sciumè, R Nunes Rodrigues, S Gräfe, F Marchesi, OA Cornely, L Pagano |
| 6 |
[GO] |
2022―Jul―12 |
Covid-19 vaccine tolerabilty in a patient with a delayed allergic reaction to polyethylene glycol: a case report |
D Loli-Ausejo, S Gómez-Armayones, J Sáez-Peñataro, MF González-Matamala, B Mascaró, R Muñoz-Cano, J Bartra |
| 7 |
[GO] |
2022―May―30 |
Tolerance to SARS-CoV-2 mRNA vaccination in a patient with challenge-confirmed PEG 2000 allergy |
V Faihs, R Bent, U Darsow, T Biedermann, K Brockow |
| 8 |
[GO] |
2022―May―30 |
Safe administration of SARS-CoV-2 vaccine after desensitization to a biologic containing polysorbate 80 in a patient with polyethylene glycol-induced severe anaphylaxis and sensitization to polysorbate 80 |
A Nin-Valencia, A Fiandor, M Lluch, S Quirce, T Caballero, R Heredia Revuelto, M González-Muñoz, ML Caballero, R Cabañas |
| 9 |
[GO] |
2022―May―09 |
Barcelona Olfactory Test - 8: validation of a new test on Spanish population during COVID-19 pandemic |
MJ Rojas-Lechuga, JC Ceballos, M Valls-Mateus, P Mackers, A Izquierdo-Domínguez, M López-Chacón, C Langdon, F Mariño-Sánchez, J Valero, J Mullol, I Alobid |
| 10 |
[GO] |
2022―May―06 |
COVID-19 Publications in Allergy Journals, 2020-2021: A Bibliometric Analysis |
CM D'Amelio, G Gastaminza, I Aquerreta, E Cacho-Asenjo, A Martinez-Simon, JM Núñez-Córdoba |
| 11 |
[GO] |
2022―Mar―01 |
Successful Covid-19 vaccination of a patient with hypersensitivity against polyethylene glycol and polysorbate |
I Hennighausen, J Pickert, S Mühlenbein, C Möbs, W Pfützner |
| 12 |
[GO] |
2022―Feb―03 |
Impact of COVID-19 on Allergy Residency Training in Spain |
G Zambrano Ibarra, T Posadas Miranda, Á Meijide Calderón, MJ Rial, I García-Gutierrez |
| 13 |
[GO] |
2021―Dec―17 |
Hypersensitivity to the Moderna COVID-19 vaccine caused by tromethamine: PEG is not always the culprit excipient |
TA Rama, RM Coutinho, D Mota, A Moreira, J Cernadas |
| 14 |
[GO] |
2021―Nov―03 |
Evaluation of fractional exhaled nitric oxide during SARS-CoV-2 infection |
D Betancor, M Valverde-Mongue, A Gomez-Lopez, B Barroso, L Ruete, JM Olaguibel, J Sastre |
| 15 |
[GO] |
2021―Sep―30 |
Viral-like reaction or hypersensitivity? Erythema multiforme minor reaction and moderate eosinophilia after receiving Pfizer-BioNTech BNT162b2 (mRNA-based SARS-CoV-2 vaccine) |
L de las Vecillas, J López, E Morchón, F Rodriguez, M Drake, M Martino |
| 16 |
[GO] |
2021―Sep―03 |
Referral criteria for asthma and the pandemic: new challenges, new responses |
J Delgado Romero, S Núñez Palomo, AM Uréndez Ruiz, F Gómez Ruiz, A Hidalgo Requena, FJ Álvarez Gutiérrez |
| 17 |
[GO] |
2021―Sep―01 |
Allergic reactions after administration of pfizer-biontech covid-19 vaccine to healthcare workers at a tertiary hospital |
D Loli-Ausejo, JM González de Abreu, A Fiandor, R Cabañas, J Domínguez-Ortega, ML Caballero, M Lluch-Bernal, C Rodrigo García-Panto, MC Núñez, S Quirce |
| 18 |
[GO] |
2021―Sep―01 |
Drug hypersensitivity in cutaneous manifestations of SARS-CoV-2 infected patients |
E Solano-Solares, V Chica-Guzmán, I Pérez-Allegue, R Cabrera-Hernández, M Fernández-Guarino, D Fernández-Nieto, C Moreno-García-del-Real, A de-Andres-Martin, L García-Bermejo, D González-de-Olano, B de-la-Hoz-Caballer |
| 19 |
[GO] |
2021―Sep―01 |
Is environmental pollen concentration a risk factor for SARS-CoV-2 infection? |
AJ Moral de Gregorio, R Guzmán Rodríguez, CJ Senent Sánchez, JA Lemus Calderón, A Valero Santiago |
| 20 |
[GO] |
2021―Jul―28 |
Polyethylene glycol allergy and immediate-type hypersensivitity reaction to COVID-19 vaccination: case report |
M Habran, M Vandebotermet, R Schrijvers |
| 21 |
[GO] |
2021―Jun―23 |
B cells and COVID-19: Lessons from agammaglobulinemia patients and the study of functional B cell polymorphisms |
M Speletas, S Raftopoulou, E Farmaki, N Gatselis, G Germanidis, V Mouchtouri, S Hatzianastasiou, S Georgiadou, G Tsinti, O Tsachouridou, M Tseroni, S Metallidis, G Dalekos, H Eibel, C Hadjichristodoulou |
| 22 |
[GO] |
2021―Jun―22 |
Kounis syndrome in a Covid-19 patient following intravenous azithromycin administration |
C Gogos, V Sachpekidis, V Moschovidis, I Styliadis, NG Kounis |
| 23 |
[GO] |
2021―Jun―15 |
Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) Including a PEG-containing COVID-19 Vaccine Revealed by Intradermal Testing |
J Pickert, I Hennighausen, S Mühlenbein, C Möbs, W Pfützner |
| 24 |
[GO] |
2021―Jun―14 |
Hypersensitivity to COVID-19 Vaccine Confirmed by a Positive Skin Test Result: A Case Report |
S Pérez-Codesido, A Rosado, MD Alonso-Díaz-de-Durana, T Alfaya Arias, A González-Moreno, MA Tejedor Alonso |
| 25 |
[GO] |
2021―May―11 |
Delayed Reaction to Gadobutrol in a Nurse with Myocarditis After SARS-CoV2 Infection |
A Gallardo, MT Gracia Bara, EM Moreno, E Laffond, FJ Muñoz Bellido, C Martin, M Sobrino, I Dávila |
| 26 |
[GO] |
2021―May―05 |
Psychiatric and Clinical Characteristics of Hereditary Angioedema Patients Who Experienced Attacks during COVID-19 |
N Mete Gökmen, O Kuman Tunçel, G Boğatekin, G Bulut, S Demir, A Gelincik, C Tunakan Dalgıç, D Mungan |
| 27 |
[GO] |
2021―Apr―13 |
COVID-19 and TEN treated with IVIG and Total plasma exchange. Simultaneous systemic treatment for both diseases |
A Krajewski, E Mlynska-Krajewska, K Kaczynska, J Strużyna, MJ Mazurek |
| 28 |
[GO] |
2021―Mar―02 |
Safety of new MRNA Vaccines Against COVID-19 in Severe Allergic Patients |
P Rojas-Pérez-Ezquerra, J Crespo Quirós, P Tornero Molina, ML Baeza Ochoa de Ocáriz, JM Zubeldia Ortuño |
| 29 |
[GO] |
2021―Feb―11 |
Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders? |
T Azenha Rama, I Álvarez-Twose |
| 30 |
[GO] |
2021―Feb―03 |
Olfactory and Gustatory dysfunction in Pediatric Population with Coronavirus Disease (COVID-19) |
M Bernaola Abraira, I Bartha De Las Peñas, GA López-Araujo, C Escudero Diez, P Rodríguez del Río, C Morales-Cabeza, R Bazire Batiz, MD Ibáñez Sandín |
| 31 |
[GO] |
2021―Jan―19 |
High frequency of smell and taste dysfunctions in allergy health care professionals suffering from COVID-19 |
DA Amérigo, JL Cubero, C Colás, I Alobid, J Mullol, A Valero |
| 32 |
[GO] |
2021―Jan―14 |
The century of mRNA vaccines: COVID-19 vaccines and allergy |
NR Ortega Rodríguez, MT Audícana Berasategui, B de la Hoz Caballer, A Valero Santiago |
| 33 |
[GO] |
2021―Jan―12 |
Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines |
ML Caballero, S Quirce |
| 34 |
[GO] |
2020―Dec―04 |
Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2: a case description |
D Pecori, P Della Siega, E Sozio, E Barbano, L Mazzoran, A Zanichelli, F Sbrana, I Federico, F Bassi, M Fabris, I Vendramin, R Sbrojavacca, C Tascini |
| 35 |
[GO] |
2020―Jul―23 |
Treating COVID-19: Review of drug hypersensitivity reactions |
MT Dordal Culla, V Herrera-Lasso Regás, J Martí-Garrido, D Rodríguez Cumplido, P Vázquez-Revuelta, R Lleonart Bellfill |
| 36 |
[GO] |
2020―Jul―02 |
COVID-19 & Allergy: Allergists Workload During the Pandemic |
I Fernández-de-Alba, C Brigido, I García-Gutierrez, D Antolín-Amérigo, S Sánchez-García |
| 37 |
[GO] |
2020―Jun―18 |
Smell and taste dysfunctions in COVID-19 are associated with younger age in ambulatory settings - a multicenter cross-sectional study |
A Izquierdo-Domínguez, MJ Rojas-Lechuga, C Chiesa-Estomba, C Calvo-Henríquez, E Ninchritz-Becerra, M Soriano-Reixach, D Poletti-Serafini, IM Villarreal, JM Maza-Solano, R Moreno-Luna, PP Villarroel, B Mateos-Serrano, D Agudelo, F Valcarcel, A del Cuvillo, A Santamaría, F Mariño-Sánchez, J Aguilar, P Vergés, A Inciarte, A Soriano, J Mullol, I Alobid |
| 38 |
[GO] |
2020―Jun―18 |
Presenting prevalence, characteristics and outcome of asthmatic patients with T2 diseases in hospitalized subjects with COVID-19 in Madrid, Spain |
B Barroso, M Valverde-Monge, JA Cañas, JM Rodrigo-Muñoz, B Gonzalez-Cano, V Villalobos-Violan, D Betancor, A Gomez-Cardeñosa, G Vallejo-Chamorro, L Baptista, C Villalobos-Vilda, L Ortega-Martin, A Gómez-López, O Sanchez-Pernaute, F Romero-Bueno, MJ Rodriguez-Nieto, V Del Pozo, J Sastre |
| 39 |
[GO] |
2020―Jun―16 |
Eosinophil Response Against Classical and Emerging Respiratory Viruses: COVID-19 |
JM Rodrigo-Muñoz, B Sastre, JA Cañas, M Gil-Martínez, N Redondo, V del Pozo |
| 40 |
[GO] |
2020―Jun―16 |
Upper and Lower Airways Functional Examination in Asthma and Respiratory Allergic Deseases. Considerations in the SARS-CoV-2 Post-Pandemic Situation |
JM Olaguibel, I Alobid, M Alvarez Puebla, A Crespo-Lessmann, J Domínguez Ortega, F García-Rio, A Izquierdo-Domínguez, J Mullol, V Plaza, S Quirce, MJ Rojas-Lechuga, M Valvere-Monge, J Sastre |
| 41 |
[GO] |
2020―Jun―08 |
Pertinence of Telehealth in a Rush Conversion to Virtual Allergy Practice during the COVID-19 Outbreak |
R González-Pérez, I Sánchez-Machín, P Poza-Guedes, V Matheu, C Álava-Cruz, E Mederos Luís |
| 42 |
[GO] |
2020―Jun―05 |
Serum concentrations of interleukin-6 (IL-6) in the general adult population: possible implications for anti-IL-6 therapy in SARS-Cov-2 infection and IL-6-related diseases |
V Alende-Castro, M Alonso-Sampedro, F Gude, A Gonzalez-Quintela |
| 43 |
[GO] |
2020―May―14 |
Olfactory dysfunction in the COVID-19 outbreak |
A Izquierdo-Dominguez, MJ Rojas-Lechuga, J Mullol, I Alobid |
| 44 |
[GO] |
2020―May―12 |
Allergen Immunotherapy in the era of SARS-CoV-2 |
E Compalati, M Erlewyn-Lajeunesse, FR Ali, P Ojeda Fernández, I Garcia Nuñez, F Frati, G Mistrello |
|
